Literature DB >> 25526302

IL-17 cuts to the chase in colon cancer.

Matthias Ernst1, Tracy Putoczki2.   

Abstract

Although interleukin-17A (IL-17A) facilitates colon cancer development, its target cells remain elusive. In this issue of Immunity, Wang et al. (2014) now demonstrate that IL-17A receptors on the intestinal epithelium promote progression of APC mutant adenomas associated with IL-6 expression and that IL-17A confers chemotherapy resistance.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25526302     DOI： 10.1016/j.immuni.2014.12.004

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  10 in total

1.  Sodium channel γENaC mediates IL-17 synergized high salt induced inflammatory stress in breast cancer cells.

Authors:  Suneetha Amara; Michael T Ivy; Elbert L Myles; Venkataswarup Tiriveedhi
Journal:  Cell Immunol       Date:  2015-12-19       Impact factor: 4.868

Review 2.  Inflammatory bowel disease and carcinogenesis.

Authors:  Hiroko Nagao-Kitamoto; Sho Kitamoto; Nobuhiko Kamada
Journal:  Cancer Metastasis Rev       Date:  2022-04-13       Impact factor: 9.237

3.  Loss of Interleukin-17RA Expression is Associated with Tumour Progression in Colorectal Carcinoma.

Authors:  Boon Yean Chai; Wai Kien Yip; Noraini Dusa; Norhafizah Mohtarrudin; Heng Fong Seow
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

Review 4.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

5.  Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling.

Authors:  Xuan Sun; Suoning Liu; Daguang Wang; Yang Zhang; Wei Li; Yuchen Guo; Hua Zhang; Jian Suo
Journal:  Oncotarget       Date:  2017-02-28

6.  A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.

Authors:  Dana Koslawsky; Marianna Zaretsky; Ron Alcalay; Ohad Mazor; Amir Aharoni; Niv Papo
Journal:  Oncotarget       Date:  2018-06-19

7.  Ex Vivo Human Colon Tissue Exposure to Pristine Graphene Activates Genes Involved in the Binding, Adhesion and Proliferation of Epithelial Cells.

Authors:  Mohamed H Lahiani; Kuppan Gokulan; Katherine Williams; Sangeeta Khare
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

8.  IL-17A in Human Liver: Significant Source of Inflammation and Trigger of Liver Fibrosis Initiation.

Authors:  Daria Kartasheva-Ebertz; Jesintha Gaston; Loriane Lair-Mehiri; Estelle Mottez; Tan-Phuc Buivan; Pierre-Philippe Massault; Olivier Scatton; Sebastien Gaujoux; Jean-Christophe Vaillant; Stanislas Pol; Sylvie Lagaye
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

9.  Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Jian-Fei Tu; Hong-Ying Pan; Xi-Hui Ying; Jian Lou; Jian-Song Ji; Hai Zou
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Early and Partial Reduction in CD4+Foxp3+ Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4+ and CD8+ T Cell Activation Inhibiting Tumorigenesis.

Authors:  Jonadab E Olguín; Itzel Medina-Andrade; Emmanuel Molina; Armando Vázquez; Thalia Pacheco-Fernández; Rafael Saavedra; Carlos Pérez-Plasencia; Yolanda I Chirino; Felipe Vaca-Paniagua; Luis E Arias-Romero; Emma B Gutierrez-Cirlos; Sonia A León-Cabrera; Miriam Rodriguez-Sosa; Luis I Terrazas
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.